Nephros Inc 

$1.88
10
+$0.03+1.62% Friday 20:00

통계

낮 최고
1.88
낮음
1.88
52W 높음
4.04
52W 낮음
1.4
거래량
436
평균 거래량
12,125
시가 총액
19.3M
주가수익률
-
배당수익률
-
배당금
-

예정

수익

6Nov예상
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
다음
-0.06
-0.05
-0.03
-0.02
예상 EPS
-0.02
실제 EPS
해당 없음

다른 인물도 팔로우하고 있습니다

이 목록은 Stock Events에서 NEPH을(를) 팔로우하는 사람들의 워치리스트에 기반한 것입니다. 이는 투자 권유가 아닙니다.

경쟁자

이 목록은 최근 시장 이벤트에 기반한 분석입니다. 투자 권장사항이 아닙니다.

애널리스트 평가

5$평균 가격 목표
가장 높은 추정치는 $5입니다.
최근 6개월 이내의 1 평가에 의한 것입니다. 이는 투자 권유가 아닙니다.
매수
0%
보유
100%
매도
0%

개요

Medical Specialties
Health Technology
Manufacturing
Surgical and Medical Instrument Manufacturing
Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Show more...
CEO
직원
31
국가
US
ISIN
US6406714005

목록